A cell therapy that cures a handful of patients in a clinical trial and one that reliably reaches thousands of patients commercially are, in practice, two very different manufacturing problems. Many promising therapies are stalling in exactly that gap, not because the underlying…
Read insight
A patient approved for a personalized cell therapy can wait weeks between having cells collected and receiving the finished treatment, because a factory somewhere has to manufacture a single, unrepeatable batch just for them. The science works. What the industry is still struggl…
Read insightA cell therapy that cures a handful of patients in a clinical trial and one that reliably reaches thousands of patients commercially are, in practice, two very…
A patient approved for a personalized cell therapy can wait weeks between having cells collected and receiving the finished treatment, because a factory somewh…
